| Assay ID | Title | Year | Journal | Article |
|---|
| AID426643 | Antiapoptotic activity against low density lipoprotein-induced apoptosis in HUVEC cells assessed as nuclear fragmentation after 24 hrs by acridin orange staining | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID426644 | Antiapoptotic activity against low density lipoprotein-induced apoptosis in HUVEC cells assessed as apoptotic cell after 24 hrs by TUNEL assay | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID265053 | Inhibition of HUVEC cell line apoptosis at 50 uM | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives. |
| AID426646 | Antiapoptotic activity against low density lipoprotein-induced vascular apoptosis in HUVEC cells assessed as inhibition of ROS by lase scanning confocal microscope | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID265054 | Inhibition of HUVEC cell line apoptosis at 100 uM | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives. |
| AID426650 | Cytotoxicity against HUVEC cells assessed as reduction in low density lipoprotein-induced cell viability at 50 uM by MTT assay | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID426648 | Antiapoptotic activity against low density lipoprotein-induced vascular apoptosis in HUVEC cells assessed as translocation of NF-kappaB across the nucleus by lase scanning confocal microscope | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID265064 | Antiproliferative activity against human A549 cell line by MTT assay | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives. |
| AID426642 | Antiapoptotic activity against low density lipoprotein-induced apoptosis in HUVEC cells by Hoechst 33258 staining | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID426641 | Antiapoptotic activity against low density lipoprotein-induced apoptosis in HUVEC cells assessed as nuclear condensation after 24 hrs by acridin orange staining | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID426645 | Antiapoptotic activity against low density lipoprotein-induced apoptosis in HUVEC cells assessed as inhibition of integrin beta4 level at 50 uM by immunofluorescence technique | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID426649 | Antiapoptotic activity against low density lipoprotein-induced vascular apoptosis in HUVEC cells assessed as modulation of P53 level by lase scanning confocal microscope | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| AID265055 | Inhibition of HUVEC cell line apoptosis at 200 uM | 2006 | Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
| Design, synthesis, and preliminary biological evaluation of 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine derivatives. |
| AID426647 | Antiapoptotic activity against low density lipoprotein-induced vascular apoptosis in HUVEC cells assessed as modulation of NF-kappaB level by lase scanning confocal microscope | 2009 | Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
| Protective effects of a benzoxazine derivative against oxidized LDL-induced apoptosis and the increases of integrin beta4, ROS, NF-kappaB and P53 in human umbilical vein endothelial cells. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |